CHIPLIGHTBIOTECH
Start with a single cell. Shorten the path to development.
Visual, low-damage single-cell manipulation connects cell loading, functional validation, screening, recovery and downstream analysis.01
ANTIBODY DRUG DEVELOPMENT
Link antibody function to sequence, cell by cell.
Import and isolate individual B cells, validate the secreted antibodies, then recover high-specificity cells for sequencing and bioinformatics analysis.
ANTIBODY DRUG DEVELOPMENT / CHIPLIGHTWORKFLOW OVERVIEW
Individual B cells are imported and isolated before their secreted antibodies undergo functional validation. Affinity and specificity against the target protein are evaluated to identify and recover high-specificity B cells.
Downstream sequencing and bioinformatics link each cell’s sequence data directly with its measured antibody function, producing antibody sequences with traceable functional evidence.
OptoBot® 1000 microwells are approximately one hundred-thousandth the volume of a 384-well plate. Media exchange supports long-term cell culture and can shorten the overall development cycle by two months.
Discuss your workflowUP TO2 months faster
MICROWELL VOLUME1 / 100,000
OUTPUTFunction-linked sequences
WORKFLOW
A traceable path from cell to result